loading…
The Advisory Council of the Indonesian Doctors Association (IDI) Zubairi Djoerban gave an explanation about this mysterious hepatitis. Photo/SINDOnews
Regarding this matter, the Advisory Council of the Indonesian Doctors Association (IDI) Zubairi Djoerban gave an explanation about this mysterious hepatitis. Read also: Three Children Died of Mysterious Hepatitis, This is IDAI’s Suggestion for the Community
“Mysterious hepatitis in children has become a hot topic recently around the world. One hundred cases were reported, including three children in Indonesia who died. What really happened?” said the man who is familiarly called Prof Zubairi in his tweet at @profesorzubairi which was confirmed by MNC Portal, Tuesday (3/5/2022).
What causes this mysterious hepatitis, Zubairi explained, experts are investigating, including in Indonesia. Some of them were found to be Adenovirus 41, some were found to be SARS-CoV2 (Coronavirus), some were a combination of the two viruses, and it was still possible to have other causes.
“What is Adenovirus? Common viruses that cause various diseases: colds, fever, sore throat, bronchitis, pneumonia, and diarrhea. Adenovirus 41 has never been associated with hepatitis, and this common pathogen is usually self-limiting,” he explained.
How to diagnose this mysterious Hepatitis, Zubairi explained that so far there has been no test that can confirm this mysterious Hepatitis. What is clear, there is a requirement that the patient must be negative for Hepatitis AE, and with an Ade transaction enzyme level of more than 500 units/liter.
“There is no definitive test yet. But the condition is that the patient must be negative for Hepatitis A, B, C, D, E viruses and with transaminase enzyme levels of more than 500 units per liter,” said Zubairi.
Anyone who is infected, according to Zubairi citing the World Health Organization (WHO), the age range identified as having contracted the mysterious Hepatitis so far is from infants 1 month to teenagers 16 years.
“According to WHO, the age range of patients identified so far is between infants aged one month to adolescents aged 16 years,” he said.
–